Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification

• Главные авторы: Virginie Philippe (Автор), Annick Jeannerat (Автор), Cédric Peneveyre (Автор), Sandra Jaccoud (Автор), Corinne Scaletta (Автор), Nathalie Hirt-Burri (Автор), Philippe Abdel-Sayed (Автор), Wassim Raffoul (Автор), Salim Darwiche (Автор), Lee Ann Applegate (Автор), Robin Martin (Автор), Alexis Laurent (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2023-09-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Cytotherapies are often necessary for the management of symptomatic large knee (osteo)-chondral defects. While autologous chondrocyte implantation (ACI) has been clinically used for 30 years, allogeneic cells (clinical-grade FE002 primary chondroprogenitors) have been investigated in translational s...